Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,088 | -9,675 | -10,915 | -5,629 | -7,460 |
| Depreciation Amortization | 12 | 9 | 9 | 12 | 30 |
| Accounts receivable | N/A | N/A | 234 | -234 | N/A |
| Other Working Capital | 803 | -626 | 1,461 | -683 | 1,770 |
| Other Operating Activity | 3,789 | 2,792 | 3,535 | 3,432 | 1,780 |
| Operating Cash Flow | $-7,484 | $-7,500 | $-5,676 | $-3,102 | $-3,880 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5 | -5 | N/A | 0 |
| Other Investing Activity | 0 | 69 | -10 | 0 | 0 |
| Investing Cash Flow | $N/A | $64 | $-15 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,609 | 10,403 | 6,067 | 5,206 | N/A |
| Other Financing Activity | 0 | 0 | 130 | 3,536 | 3,820 |
| Financing Cash Flow | $8,609 | $10,403 | $6,197 | $8,742 | $3,820 |
| Beginning Cash Position | 9,364 | 6,397 | 5,891 | 251 | 310 |
| End Cash Position | 10,489 | 9,364 | 6,397 | 5,891 | 250 |
| Net Cash Flow | $1,125 | $2,967 | $506 | $5,640 | $-60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,484 | -7,500 | -5,676 | -3,102 | -3,880 |
| Capital Expenditure | N/A | -5 | -5 | N/A | N/A |
| Free Cash Flow | -7,484 | -7,505 | -5,681 | -3,102 | -3,880 |